ANTHELIOS SX Drug Patent Profile
✉ Email this page to a colleague
When do Anthelios Sx patents expire, and when can generic versions of Anthelios Sx launch?
Anthelios Sx is a drug marketed by Loreal Usa and is included in one NDA.
The generic ingredient in ANTHELIOS SX is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.
Summary for ANTHELIOS SX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ANTHELIOS SX at DailyMed |
Recent Clinical Trials for ANTHELIOS SX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Loreal USA | Phase 4 |
US Patents and Regulatory Information for ANTHELIOS SX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ANTHELIOS SX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
| Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ANTHELIOS SX
See the table below for patents covering ANTHELIOS SX around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 1204779 | 3-BENZYLIDENE CAMPHRES, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION POUR LA PROTECTION CONTRE LES RAYONS UV (3-BENZYLIDENE CAMPHORS; PROCESS FOR PREPARING THE SAME AND THEIR USE AS PROTECTIVE AGENTS AGAINST UV RADIATION) | ⤷ Try a Trial |
| European Patent Office | 0514491 | COMPOSITION COSMETIQUE FILTRANTE PHOTOSTABLE CONTENANT UN FILTRE UV-A ET UN BETA, BETA-DIPHENYLACRYLATE OU ALPHA-CYANO-BETA, BETA-DIPHENYLACRYLATE D'ALKYLE. (LIGHT-RESISTANT FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND AN ALKYL BETA, BETA-DIPHENYLACRYLATE OR AN ALKYL ALPHA-CYANO-BETA, BETA-DIPHENYLACRYLATE.) | ⤷ Try a Trial |
| Spain | 2060370 | ⤷ Try a Trial | |
| Italy | 1162877 | NUOVE 3 BENZILIDENCANFORE LORO PROCEDIMENTO DI PREPARAZIONE E LORO UTILIZZAZIONE PER LA PROTEZIONE CONTRO I RAGGI ULTRAVIOLETTI | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
